Neogen (NEOG) Capital Expenditures Growth (5y) (2015 - 2026)
Neogen (NEOG) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 6.98% |
| Nov 30, 2025 | 11.26% |
| Aug 31, 2025 | 41.39% |
| May 31, 2025 | 15.80% |
| Feb 28, 2025 | 56.41% |
| Nov 30, 2024 | 22.04% |
| Aug 31, 2024 | 42.81% |
| May 31, 2024 | 54.18% |
| Feb 29, 2024 | 44.17% |
| Nov 30, 2023 | 38.44% |
| Aug 31, 2023 | 74.04% |
| May 31, 2023 | 40.56% |
| Feb 28, 2023 | 20.81% |
| Nov 30, 2022 | 15.10% |
| Aug 31, 2022 | 24.10% |
| May 31, 2022 | 51.40% |
| Feb 28, 2022 | -0.32% |
| Nov 30, 2021 | 7.13% |
| Aug 31, 2021 | -17.78% |
| May 31, 2021 | 18.92% |